Day One Biopharmaceuticals, Inc.
DAWN
Price:
$8.34
Market Cap:
$856.31M
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Industry
Biotechnology
IPO Date
2021-05-27
Stock Exchange
NASDAQ
Ticker
DAWN
PE Ratio
[-5.49]
ROE
[-32.05%]
Current Ratio
[8.68]
Dividend Yield
[0%]
Enterprise Value
[815.93M]
Dividend History
The ROE as of December 2025 (TTM) for Day One Biopharmaceuticals, Inc. (DAWN) is -32.05%
According to Day One Biopharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -32.05%. This represents a change of 306.57% compared to the average of -7.88% of the last 4 quarters.
Day One Biopharmaceuticals, Inc. (DAWN) Historical ROE (quarterly & annually)
How has DAWN ROE performed in the past?
The mean historical ROE of Day One Biopharmaceuticals, Inc. over the last ten years is 40.55%. The current -32.05% ROE has changed -179.03% with respect to the historical average. Over the past ten years (40 quarters), DAWN's ROE was at its highest in in the December 2021 quarter at 93.99%. The ROE was at its lowest in in the March 2024 quarter at -21.03%.
Average
40.55%
Median
52.13%
Minimum
-54.52%
Maximum
137.83%
Day One Biopharmaceuticals, Inc. (DAWN) ROE by Quarter and Year
Discovering the peaks and valleys of Day One Biopharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 137.83%
Minimum Annual Increase = -211.22%
Minimum Annual ROE = -54.52%
| Year | ROE | Change |
|---|---|---|
| 2024 | -18.99% | -65.16% |
| 2023 | -54.52% | -211.22% |
| 2022 | 49.01% | -11.29% |
| 2021 | 55.25% | -26.06% |
| 2020 | 74.73% | -45.78% |
Day One Biopharmaceuticals, Inc. (DAWN) Average ROE
How has DAWN ROE performed in the past?
The current ROE of Day One Biopharmaceuticals, Inc. (DAWN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-8.17%
5-year avg
21.10%
10-year avg
40.55%
Day One Biopharmaceuticals, Inc. (DAWN) ROE vs. Peers
How is DAWN’s ROE compared to its peers?
Day One Biopharmaceuticals, Inc.’s ROE is greater than Geron Corporation (-30.28%), greater than Valneva SE (-35.27%), greater than Arvinas, Inc. (-9.77%), greater than Replimune Group, Inc. (-69.34%), greater than Tyra Biosciences, Inc. (-31.80%), greater than Rezolute, Inc. (-62.82%), greater than ArriVent BioPharma, Inc. Common Stock (-55.48%), greater than Astria Therapeutics, Inc. (-38.63%), greater than Erasca, Inc. (-31.19%), greater than Vir Biotechnology, Inc. (-50.22%),
| Company | ROE | Market cap |
|---|---|---|
| -30.28% | $810.71M | |
| -35.27% | $742.49M | |
| -9.77% | $911.69M | |
| -69.34% | $825.97M | |
| -31.80% | $1.18B | |
| -62.82% | $899.46M | |
| -55.48% | $1.01B | |
| -38.63% | $748.95M | |
| -31.19% | $905.04M | |
| -50.22% | $943.19M |
Build a custom stock screener for Day One Biopharmaceuticals, Inc. (DAWN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Day One Biopharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Day One Biopharmaceuticals, Inc. (DAWN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Day One Biopharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Day One Biopharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Day One Biopharmaceuticals, Inc. (DAWN)?
What is the highest ROE for Day One Biopharmaceuticals, Inc. (DAWN)?
What is the 3-year average ROE for Day One Biopharmaceuticals, Inc. (DAWN)?
What is the 5-year average ROE for Day One Biopharmaceuticals, Inc. (DAWN)?
How does the current ROE for Day One Biopharmaceuticals, Inc. (DAWN) compare to its historical average?